Fortfahren mit
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Packungsgröße | SKU | Verfügbarkeit | Preis |
|---|---|---|---|
| 30 mg | Warenkorb auf Verfügbarkeit prüfen | CHF 1’230.00 |
Über diesen Artikel
Empirische Formel (Hill-System):
C19H20FNO3 · HCl · 0.5H2O
Molekulargewicht:
374.83
NACRES:
NA.24
UNSPSC Code:
41116107
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltengrade
pharmaceutical primary standard
API family
paroxetine
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Paroxetine Related Compound C USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monograph such as Paroxetine Hydrochloride.
Also, for use with USP monograph such as Paroxetine Hydrochloride.
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.
Still not finding the right product?
Explore all of our products under Paroxetin-verwandte Verbindung C
signalword
Danger
Lagerklasse
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Repr. 2
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Małgorzata Lisowska-Kuźmicz et al.
Analytical and bioanalytical chemistry, 406(15), 3697-3702 (2014-01-11)
A new chromatographic method for the enantioseparation and the determination of (-)-trans-paroxetine and (+)-trans-paroxetine has been developed with the aid of amylose ovomucoid-based chiral stationary phase. The method is faster and five times more sensitive than procedures recommended previously: limit
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 1500240-30MG | 04061838670045 |